Revio is an innovative gene sequencing machine revolutionizing human genetic analysis, cancer research, and agricultural genomics. It performs genetic diagnostic tests, uncovering underlying genetic diseases, deciphering cancer’s complex genomic structure and characterizing infectious viruses, microbes and rare diseases. With the ability to sequence 1,500 whole human genomes per year at a cost of under $1,000 per genome, Revio is a true breakthrough.

As an all-in-one genomic sequencing machine, Revio features a light-tight and temperature-controlled test chamber with genetic material sample cell trays, a robotic arm, and a waste bin. It boasts two user interface displays, providing set-up, status, and results information. Designed to be highly effective, user-friendly, compact and visually appealing, Revio represents the cutting edge of life science technology, contributing directly to the quality of life.

Revio’s design innovation incorporates advanced technologies, components, and process steps into a single machine. It offers unparalleled performance, throughput, and accuracy, setting a new gold standard in genetic science. The simplified and optimized operational sequence is supported by a sleek dual-screen user interface enhancing user experience.
The physical work deck is ergonomically optimized for easy access to SMRT cells, reagents, and disposables, while a wide door ensures maximum visibility and access. The user-friendly design reduces errors and increases throughput.

Revio benefits users with improved performance, throughput, human factors, a small footprint and lower testing costs. It offers an integrated end-to-end workflow, controlled through two touchscreen interfaces, allowing real-time monitoring and data management across multiple instruments and remote desktops. The intuitive user interface architecture and logical categorization of operations streamline machine operation. Revio’s consumable growth has soared by 24%, generating an annual revenue of $59.9 million.

From a brand perspective, Revio has catapulted PacBio to the forefront of genomics. It has become PacBio’s most successful product, driving brisk sales and establishing a significant revenue stream through consumables. With its unmatched performance and compact design, Revio outshines competitors.

By unraveling the complexities of human genome sequencing, Revio contributes to a deeper understanding of diseases like cancer and rare genetic conditions. It enables researchers worldwide to access higher throughput and lower sequencing project costs. Additionally, Revio’s eco-friendly design reduces hazardous waste by 50% through fewer consumables.

Aesthetically, Revio breaks new ground in large test equipment. Its distinct cubic form is divided into three vertical color blocks, inspired by genetic sequence maps. The precise details, such as the back-painted gorilla glass sliding door with a touchscreen display, the woven wire ventilation grill, reflect sophistication, competence and precision. The fit and finish of Revio exhibit meticulous attention to detail, while the aesthetically pleasing digital user interface ensures intuitive machine operation.

Category:MedicalYear:2023Designer:Cole Derby, Dan Harden, Akifusa Nakazawa, Grace Budgett, Walker Harden, Mike Dong, Alice Chen, Whipsaw, San Francisco, California, USAManufacturer:Pacific Biosciences, Menlo Park, California, USA